Impact of Glucose-Lowering Medications on COPD Exacerbations in Type 2 Diabetes Patients
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RAs) are two classes of medication that have gained significant attention ...
